Expert Review of Anti-Infective Therapy

And now for something completely simple
pp. 1-4(4)
Authors: Conway, Brian; DeVlaming, Stanley

News in Brief
pp. 5-8(4)

Disease Watch
pp. 8-8(1)

Thymalfasin for the treatment of chronic hepatitis B
pp. 9-16(8)
Authors: Chien, Rong-Nan; Liaw, Yun-Fan

Peginterferon-α2b and ribavirin
pp. 17-25(9)
Authors: Ahn, Joseph; Flamm, Steven

Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts
pp. 27-41(15)
Authors: Razonable, Raymund R; Paya, Carlos V

Nitazoxanide: a new broad spectrum antiparasitic agent
pp. 43-49(7)
Author: White Jr, A Clinton

A review of linezolid: the first oxazolidinone antibiotic
pp. 51-59(9)
Authors: Stevens, Dennis L; Dotter, Brian; Madaras-Kelly, Karl

Can virulence factors be viable antibacterial targets?
pp. 61-72(12)
Author: Marra, Andrea

New trends in the management of tetanus
pp. 73-84(12)
Authors: Attygalle, Deepthi; Rodrigo, Nalini

Sporotrichosis: a forgotten disease in the drug research agenda
pp. 85-94(10)
Authors: Bustamante, Beatriz; Campos, Pablo E

Emerging trends in infections among renal transplant recipients
pp. 95-109(15)
Authors: Varon, Nestor F; Alangaden, George J

Chronic cough in children: recent advances
pp. 111-117(7)
Authors: Velissariou, Ioanna M; Kafetzis, Dimitris A

Malaria chemoprophylaxis: when should we use it and what are the options?
pp. 119-132(14)
Author: Petersen, Eskild

Hepatitis B mother-to-child transmission
pp. 133-145(13)
Authors: Ranger-Rogez, Sylvie; Denis, Fran¸ois

The impact of the M184V substitution on drug resistance and viral fitness
pp. 147-151(5)
Author: Wainburg, Mark A

Management of anaerobic infection
pp. 153-158(6)
Author: Brook, Itzhak